glp-1 news september 26 2025 Uptake by Country: Where Ozempic and Mounjaro are Booming in 2026 Stopping and restarting GLP-1s may

The litigation follows FDA safety warnings about compounded semaglutide, which the agency does not review for safety or efficacy

FDA & Compounding Disclaimers 1

Isaacs says youre likely to experience more side effects while on higher doses of semaglutide

Every single time I return, whether its been a consistent weekly appointment or time has lapsed since Ive scheduled a service, I ALWAYS get the D

Weight loss typically accelerates as doses increase during the titration period

If there are no GI symptoms but the drug was not DCd as suggested, treat as full stomach, evaluate contents with ultrasound, and consider delaying the procedure